The overexpression of sortilin in bladder tumor cells and its potential in inducing apoptosis via directed targeting with the specific monoclonal antibody may represent potent as a potential candidate of targeted therapy in bladder carcinoma. This evidence concerns the gene SORT1 and urinary bladder carcinoma.